BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11727405)

  • 1. Oral therapies for diabetic hyperglycemia.
    Lebovitz HE
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):909-33. PubMed ID: 11727405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
    Lebovitz HE
    Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the role of basal and prandial insulin for optimal glycemic control.
    Horton ES
    J Am Coll Cardiol; 2009 Feb; 53(5 Suppl):S21-7. PubMed ID: 19179213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current methods of glucose metabolism control in diabetes mellitus].
    Scarpitta AM; Sinagra D
    Recenti Prog Med; 2003 Jan; 94(1):31-40. PubMed ID: 12632998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The current aspects of the pharmacological correction of hyperglycemia in patients with non-insulin-dependent diabetes mellitus (type 2)].
    Gorbenko NI
    Eksp Klin Farmakol; 1999; 62(5):71-8. PubMed ID: 10572759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus].
    Cosmi F; Cosmi D
    G Ital Cardiol (Rome); 2010 Jun; 11(6):460-6. PubMed ID: 20922871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of nateglinide on insulin resistance in type 2 diabetes.
    Hazama Y; Matsuhisa M; Ohtoshi K; Gorogawa S; Kato K; Kawamori D; Yoshiuchi K; Nakamura Y; Shiraiwa T; Kaneto H; Yamasaki Y; Hori M
    Diabetes Res Clin Pract; 2006 Mar; 71(3):251-5. PubMed ID: 16214255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of postprandial hyperglycemia in type 2 diabetes.
    Fasy EA; Buse JB
    Postgrad Med; 2001 Dec; 110(6 Suppl):14-9. PubMed ID: 19667580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin therapy in type 2 diabetes.
    Mudaliar S; Edelman SV
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.
    Chen HS; Wu TE; Jap TS; Hsiao LC; Lee SH; Lin HD
    Diabetes Care; 2008 Oct; 31(10):1927-32. PubMed ID: 18556343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report.
    Kaneko K; Satake C; Izumi T; Tanaka M; Yamamoto J; Asai Y; Sawada S; Imai J; Yamada T; Katagiri H
    BMC Endocr Disord; 2019 Jan; 19(1):5. PubMed ID: 30621663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of Saxagliptin and Metformin Is Effective as Initial Therapy in New-Onset Type 2 Diabetes Mellitus With Severe Hyperglycemia.
    Amblee A; Lious D; Fogelfeld L
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2528-35. PubMed ID: 27144930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes.
    Mori Y; Itoh Y; Obata T; Tajima N
    Endocrine; 2006 Feb; 29(1):143-8. PubMed ID: 16622303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological treatment of postprandial hyperglycemia].
    Blickle JF
    Diabetes Metab; 2000 Jun; 26 Suppl 2():20-4. PubMed ID: 10975046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.
    Abdul-Ghani MA; Norton L; DeFronzo RA
    Curr Diab Rep; 2012 Jun; 12(3):230-8. PubMed ID: 22528597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple therapeutic combination for type 2 diabetes.
    Yki-Järvinen H
    Hosp Pract (1995); 2000 Jul; 35(7):63-6, 72-4. PubMed ID: 10916505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perioperative metabolism control of diabetic and non-diabetic patients].
    Ballwieser DA; Chappell D; Jacob M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2011 Apr; 46(4):258-66; quiz 267. PubMed ID: 21484621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes. Paradoxical effects of tightly controlled blood sugar.
    Taubes G
    Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of type 2 diabetes: new or previous agents, how to choose?].
    Halimi S
    Presse Med; 2013 May; 42(5):861-70. PubMed ID: 23643613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.